St. Jude Clinical Trials
-
COVID-19 Pediatric Vaccine Studies
St. Jude is planning to participate in clinical trials to test COVID-19 prevention vaccines in healthy children. Find out more.
BIVAX: COVID-19 Pediatric Vaccine Study
BIVAX: COVID-19 Pediatric Vaccine Study
Diseases Treated:
COVID-19
Eligibility:
- 6 months to less than 5 years
- In good health
- Have not received a COVID-19 vaccine in the past
SENDAI: A Phase I Study of Unmodified Live Intranasal Sendai Virus Vaccine in Children and Toddlers: Assessment of Safety and Immunogenicity
Eligibility:
- Child is greater than or equal to twelve (12) months and less than twenty-four (24) months.
- Child has adequate blood, liver and kidney function.
- Child has no history of lung disease, asthma, and hospitalization for respiratory illness, immunodeficiency, sickle cell disease, or any other serious underlying condition.